Senseonics Holdings (SENS) Cash & Current Investments (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Cash & Current Investments came in at $240.6 million in Q2 2026, up 8.73% year-over-year from $221.3 million in Q2 2025, and up 143.01% quarter-over-quarter from $99.0 million in Q1 2026.
Analysis
Senseonics Holdings (SENS) Cash & Current Investments (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Cash & Current Investments for 13 consecutive years, with $240.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Current Investments rose 8.73% year-over-year to $240.6 million in Q2 2026; TTM through Jun 2026 was $240.6 million, a 8.73% increase from a year earlier, with the FY2025 full-year figure at $94.0 million, up 25.52% from the prior year.
- Cash & Current Investments was $240.6 million for Q2 2026 at Senseonics Holdings, up from $99.0 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $281.7 million in Q3 2022 and troughed at $74.9 million in Q4 2024.
- A 5-year average of $169.3 million and a median of $165.8 million in 2022 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments plunged 51.41% in 2024 and surged 64.69% in 2025, its largest moves.
- Over 5 years, Cash & Current Investments stood at $144.0 million in 2022, then declined by 24.0% to $109.5 million in 2023, then slumped by 31.56% to $74.9 million in 2024, then grew by 25.52% to $94.0 million in 2025, then surged by 155.88% to $240.6 million in 2026.
- The last three Cash & Current Investments figures came in at $240.6 million (Q2 2026), $99.0 million (Q1 2026), and $94.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Senseonics Holdings | 507.86 Mn | 267.25 Mn | 8.56 Mn | 240.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240.61 Mn |
| Mar 31, 2026 | 99.01 Mn |
| Dec 31, 2025 | 94.03 Mn |
| Sep 30, 2025 | 187.49 Mn |
| Jun 30, 2025 | 221.29 Mn |
| Mar 31, 2025 | 89.13 Mn |
| Dec 31, 2024 | 74.91 Mn |
| Sep 30, 2024 | 121.88 Mn |
| Jun 30, 2024 | 134.37 Mn |
| Mar 31, 2024 | 106.87 Mn |
| Dec 31, 2023 | 109.46 Mn |
| Sep 30, 2023 | 195.05 Mn |
| Jun 30, 2023 | 214.17 Mn |
| Mar 31, 2023 | 219.96 Mn |
| Dec 31, 2022 | 144.02 Mn |
| Sep 30, 2022 | 281.72 Mn |
| Jun 30, 2022 | 244.26 Mn |
| Mar 31, 2022 | 269.66 Mn |
| Dec 31, 2021 | 129.91 Mn |
| Sep 30, 2021 | 297.67 Mn |